1. Home
  2. XPOF vs CCCC Comparison

XPOF vs CCCC Comparison

Compare XPOF & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$3.98

Market Cap

205.6M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$3.38

Market Cap

404.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPOF
CCCC
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
404.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
XPOF
CCCC
Price
$3.98
$3.38
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$8.13
$12.20
AVG Volume (30 Days)
541.9K
2.2M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
35.24
16.45
EPS
N/A
N/A
Revenue
$11,092,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$3.83
$1.69
52 Week High
$9.25
$5.17

Technical Indicators

Market Signals
Indicator
XPOF
CCCC
Relative Strength Index (RSI) 24.59 34.79
Support Level $3.83 $2.41
Resistance Level $6.15 $3.91
Average True Range (ATR) 0.29 0.20
MACD -0.08 -0.08
Stochastic Oscillator 10.17 6.57

Price Performance

Historical Comparison
XPOF
CCCC

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: